BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nielsen SU, Bassendine MF, Martin C, Lowther D, Purcell PJ, King BJ, Neely D, Toms GL. Characterization of hepatitis C RNA-containing particles from human liver by density and size. J Gen Virol. 2008;89:2507-2517. [PMID: 18796720 DOI: 10.1099/vir.0.2008/000083-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Viruses. 2013;5:1292-1324. [PMID: 23698400 DOI: 10.3390/v5051292] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 11.6] [Reference Citation Analysis]
2 Gondar V, Molina-Jiménez F, Hishiki T, García-Buey L, Koutsoudakis G, Shimotohno K, Benedicto I, Majano PL. Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus. J Virol 2015;89:9962-73. [PMID: 26202245 DOI: 10.1128/JVI.00577-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
3 Beilstein F, Lemasson M, Pène V, Rainteau D, Demignot S, Rosenberg AR. Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: impact on production of lipo-viro-particles. Gut 2017;66:2160-9. [PMID: 27582510 DOI: 10.1136/gutjnl-2016-311508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
4 Merz A, Long G, Hiet MS, Brügger B, Chlanda P, Andre P, Wieland F, Krijnse-Locker J, Bartenschlager R. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem. 2011;286:3018-3032. [PMID: 21056986 DOI: 10.1074/jbc.m110.175018] [Cited by in Crossref: 259] [Cited by in F6Publishing: 170] [Article Influence: 23.5] [Reference Citation Analysis]
5 Syed GH, Amako Y, Siddiqui A. Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab. 2010;21:33-40. [PMID: 19854061 DOI: 10.1016/j.tem.2009.07.005] [Cited by in Crossref: 227] [Cited by in F6Publishing: 223] [Article Influence: 18.9] [Reference Citation Analysis]
6 Jung BK, Kim HR, Park GN, Luo G, Chang KS. Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a. J Microbiol 2016;54:451-8. [PMID: 27225463 DOI: 10.1007/s12275-016-6099-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Song X, Gao X, Wang Y, Raja R, Zhang Y, Yang S, Li M, Yao Z, Wei L. HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages. Front Immunol 2021;12:654998. [PMID: 34531848 DOI: 10.3389/fimmu.2021.654998] [Reference Citation Analysis]
8 Guo X, Wang S, Qiu ZG, Dou YL, Liu WL, Yang D, Shen ZQ, Chen ZL, Wang JF, Zhang B, Wang XW, Guo XF, Zhang XL, Jin M, Li JW. Efficient replication of blood-borne hepatitis C virus in human fetal liver stem cells. Hepatology 2017;66:1045-57. [PMID: 28407288 DOI: 10.1002/hep.29211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Syed GH, Khan M, Yang S, Siddiqui A. Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles. J Virol 2017;91:e00499-17. [PMID: 28515296 DOI: 10.1128/JVI.00499-17] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
10 Icard V, Diaz O, Scholtes C, Perrin-Cocon L, Ramière C, Bartenschlager R, Penin F, Lotteau V, André P. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS One. 2009;4:e4233. [PMID: 19156195 DOI: 10.1371/journal.pone.0004233] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
11 Jiang J, Luo G. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J Virol. 2009;83:12680-12691. [PMID: 19793818 DOI: 10.1128/jvi.01476-09] [Cited by in Crossref: 191] [Cited by in F6Publishing: 119] [Article Influence: 15.9] [Reference Citation Analysis]
12 Felmlee DJ, Sheridan DA, Bridge SH, Nielsen SU, Milne RW, Packard CJ, Caslake MJ, McLauchlan J, Toms GL, Neely RD. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology. 2010;139:1774-1783, 1783.e1-e6. [PMID: 20682323 DOI: 10.1053/j.gastro.2010.07.047] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
13 Herker E, Ott M. Unique ties between hepatitis C virus replication and intracellular lipids. Trends Endocrinol Metab 2011;22:241-8. [PMID: 21497514 DOI: 10.1016/j.tem.2011.03.004] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 8.0] [Reference Citation Analysis]
14 Qiao L, Luo GG. Functional Characterization of Apolipoproteins in the HCV Life Cycle. Methods Mol Biol. 2019;1911:235-246. [PMID: 30593630 DOI: 10.1007/978-1-4939-8976-8_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Stefas I, Tigrett S, Dubois G, Kaiser M, Lucarz E, Gobby D, Bray D, Ellerbrok H, Zarski JP, Veas F. Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus. PLoS One 2015;10:e0140900. [PMID: 26502286 DOI: 10.1371/journal.pone.0140900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Skardasi G, Chen AY, Michalak TI. Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro. J Virol 2018;92:e01790-17. [PMID: 29167333 DOI: 10.1128/JVI.01790-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Perrin-Cocon L, Diaz O, André P, Lotteau V. Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie. 2013;95:103-108. [PMID: 22959067 DOI: 10.1016/j.biochi.2012.08.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
18 Benedicto I, Gondar V, Molina-Jiménez F, García-Buey L, López-Cabrera M, Gastaminza P, Majano PL. Clathrin mediates infectious hepatitis C virus particle egress. J Virol 2015;89:4180-90. [PMID: 25631092 DOI: 10.1128/JVI.03620-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
19 Grassi G, Di Caprio G, Fimia GM, Ippolito G, Tripodi M, Alonzi T. Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenterol 2016; 22(6): 1953-1965 [PMID: 26877603 DOI: 10.3748/wjg.v22.i6.1953] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
20 Falcón V, Acosta-Rivero N, González S, Dueñas-Carrera S, Martinez-Donato G, Menéndez I, Garateix R, Silva JA, Acosta E, Kourı J. Ultrastructural and biochemical basis for hepatitis C virus morphogenesis. Virus Genes 2017;53:151-64. [PMID: 28233195 DOI: 10.1007/s11262-017-1426-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Bartosch B, Dubuisson J. Recent advances in hepatitis C virus cell entry. Viruses 2010;2:692-709. [PMID: 21994653 DOI: 10.3390/v2030692] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
22 Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection. J Virol 2016;90:9632-43. [PMID: 27535051 DOI: 10.1128/JVI.01353-16] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
23 Honda A, Matsuzaki Y. Cholesterol and chronic hepatitis C virus infection. Hepatol Res 2011;41:697-710. [PMID: 21682830 DOI: 10.1111/j.1872-034X.2011.00838.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Pène V, Lemasson M, Harper F, Pierron G, Rosenberg AR. Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis. PLoS One 2017;12:e0175810. [PMID: 28437468 DOI: 10.1371/journal.pone.0175810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Camus G, Vogt DA, Kondratowicz AS, Ott M. Lipid droplets and viral infections. Methods Cell Biol 2013;116:167-90. [PMID: 24099293 DOI: 10.1016/B978-0-12-408051-5.00009-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
26 Amako Y, Syed GH, Siddiqui A. Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J Biol Chem. 2011;286:11265-11274. [PMID: 21285358 DOI: 10.1074/jbc.m110.182097] [Cited by in Crossref: 67] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
27 Shao LN, Zhou SH, Wang N, Zhang ST, Liu M. Association between the Genetic Polymorphisms of CCL2, CCL5, CCL8, CCR2, and CCR5 with Chronic Hepatitis C Virus Infection in the Chinese Han Population. Immunol Invest 2021;:1-16. [PMID: 33902378 DOI: 10.1080/08820139.2021.1916524] [Reference Citation Analysis]
28 Fahey S, Dempsey E, Long A. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol 2014;11:25-40. [PMID: 23954947 DOI: 10.1038/cmi.2013.37] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
29 Liefhebber JM, Hague CV, Zhang Q, Wakelam MJ, McLauchlan J. Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus. J Biol Chem. 2014;289:21276-21288. [PMID: 24917668 DOI: 10.1074/jbc.m114.582999] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 5.1] [Reference Citation Analysis]
30 Schöbel A, Rösch K, Herker E. Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes. Sci Rep 2018;8:3893. [PMID: 29497123 DOI: 10.1038/s41598-018-22243-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
31 Tao J, Kang KD, Hall SD, Laube AH, Liu J, Renfrow MB, Novak J, Luo G. The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection. J Virol 2015;89:6782-91. [PMID: 25903344 DOI: 10.1128/JVI.00194-15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Guevara J Jr, Prashad N, Ermolinsky B, Gaubatz JW, Kang D, Schwarzbach AE, Loose DS, Guevara NV. Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res 2010;51:1704-18. [PMID: 20173184 DOI: 10.1194/jlr.M003277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
33 Jones DM, McLauchlan J. Hepatitis C virus: assembly and release of virus particles. J Biol Chem. 2010;285:22733-22739. [PMID: 20457608 DOI: 10.1074/jbc.r110.133017] [Cited by in Crossref: 78] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
34 Bartenschlager R, Penin F, Lohmann V, André P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011;19:95-103. [PMID: 21146993 DOI: 10.1016/j.tim.2010.11.005] [Cited by in Crossref: 310] [Cited by in F6Publishing: 302] [Article Influence: 28.2] [Reference Citation Analysis]
35 Scholtes C, Ramière C, Rainteau D, Perrin-Cocon L, Wolf C, Humbert L, Carreras M, Guironnet-Paquet A, Zoulim F, Bartenschlager R. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology. 2012;56:39-48. [PMID: 22290760 DOI: 10.1002/hep.25628] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
36 Akazawa D, Morikawa K, Omi N, Takahashi H, Nakamura N, Mochizuki H, Date T, Ishii K, Suzuki T, Wakita T. Production and characterization of HCV particles from serum-free culture. Vaccine 2011;29:4821-8. [PMID: 21550372 DOI: 10.1016/j.vaccine.2011.04.069] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
37 Sheridan DA, Hajarizadeh B, Fenwick FI, Matthews GV, Applegate T, Douglas M, Neely D, Askew B, Dore GJ, Lloyd AR, George J, Bassendine MF, Grebely J. Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection. Liver Int 2016;36:1774-82. [DOI: 10.1111/liv.13176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
38 Shimotohno K. HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems. Cold Spring Harb Perspect Med. 2021;11. [PMID: 32122916 DOI: 10.1101/cshperspect.a036814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
39 Khan M, Jahan S, Khaliq S, Ijaz B, Ahmad W, Samreen B, Hassan S. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Arch Virol 2010;155:1735-53. [DOI: 10.1007/s00705-010-0797-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
40 Sidorkiewicz M. Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites 2021;11:273. [PMID: 33925362 DOI: 10.3390/metabo11050273] [Reference Citation Analysis]
41 McLauchlan J. Lipid droplets and hepatitis C virus infection. Biochim Biophys Acta 2009;1791:552-9. [PMID: 19167518 DOI: 10.1016/j.bbalip.2008.12.012] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
42 Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RDG. Lipids and HCV. Semin Immunopathol 2013;35:87-100. [DOI: 10.1007/s00281-012-0356-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.8] [Reference Citation Analysis]